These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents. Schiefer IT; VandeVrede L; Fa' M; Arancio O; Thatcher GR J Med Chem; 2012 Apr; 55(7):3076-87. PubMed ID: 22429006 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of Ocotillol-Type Ginsenosides. Shen R; Cao X; Laval S; Sun J; Yu B J Org Chem; 2016 Nov; 81(21):10279-10294. PubMed ID: 27400182 [TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs. López GV; Batthyány C; Blanco F; Botti H; Trostchansky A; Migliaro E; Radi R; González M; Cerecetto H; Rubbo H Bioorg Med Chem; 2005 Oct; 13(20):5787-96. PubMed ID: 15993614 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292 [TBL] [Abstract][Full Text] [Related]
26. [Synthesis and antithrombotic activity of acetylsalicyl ferulic acid-coupling furoxans and nitrates]. Zhou Z; Jiang LY; Zhang YH; Ji H; Sun Y; Peng SX Yao Xue Xue Bao; 2006 Nov; 41(11):1050-6. PubMed ID: 17262946 [TBL] [Abstract][Full Text] [Related]
27. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies. Boiani L; Aguirre G; González M; Cerecetto H; Chidichimo A; Cazzulo JJ; Bertinaria M; Guglielmo S Bioorg Med Chem; 2008 Sep; 16(17):7900-7. PubMed ID: 18706821 [TBL] [Abstract][Full Text] [Related]
28. Recent Developments in Drug Design of NO-donor Hybrid Compounds. Sharma R; Joubert J; Malan SF Mini Rev Med Chem; 2018; 18(14):1175-1198. PubMed ID: 29663881 [TBL] [Abstract][Full Text] [Related]
30. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities. Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109 [TBL] [Abstract][Full Text] [Related]
31. The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil. Maccallini C; Pietrangelo T; Mancinelli R; Amoroso R; Bettoni G; Fulle S Nitric Oxide; 2008 May; 18(3):168-75. PubMed ID: 18177746 [TBL] [Abstract][Full Text] [Related]
33. Phenylsulfonylfuroxan NO-donor phenols: Synthesis and multifunctional activities evaluation. Xie Y; Yang Y; Li S; Xu Y; Lu W; Chen Z; Yang G; Li Y; Cao Y; Bian X Bioorg Med Chem; 2017 Aug; 25(16):4407-4413. PubMed ID: 28651914 [TBL] [Abstract][Full Text] [Related]
34. Water soluble furoxan derivatives as NO prodrugs. Sorba G; Medana C; Fruttero R; Cena C; Di Stilo A; Galli U; Gasco A J Med Chem; 1997 Feb; 40(4):463-9. PubMed ID: 9046336 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and antimalarial activities of some furoxan sulfones and related furazans. Galli U; Lazzarato L; Bertinaria M; Sorba G; Gasco A; Parapini S; Taramelli D Eur J Med Chem; 2005 Dec; 40(12):1335-40. PubMed ID: 15979766 [TBL] [Abstract][Full Text] [Related]
36. Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies. Aguirre G; Boiani M; Cerecetto H; Fernández M; González M; León E; Pintos C; Raymondo S; Arredondo C; Pacheco JP; Basombrío MA Pharmazie; 2006 Jan; 61(1):54-9. PubMed ID: 16454207 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents. Ling Y; Ye X; Ji H; Zhang Y; Lai Y; Peng S; Tian J Bioorg Med Chem; 2010 May; 18(10):3448-56. PubMed ID: 20435479 [TBL] [Abstract][Full Text] [Related]
38. Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells. Sodano F; Gazzano E; Rolando B; Marini E; Lazzarato L; Fruttero R; Riganti C; Gasco A Bioorg Chem; 2021 Jun; 111():104911. PubMed ID: 33901795 [TBL] [Abstract][Full Text] [Related]
39. Molecular Hybridization Tools in the Development of Furoxan-Based NO-Donor Prodrugs. Fershtat LL; Makhova NN ChemMedChem; 2017 May; 12(9):622-638. PubMed ID: 28371340 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives. Wan Q; Deng Y; Huang Y; Yu Z; Wang C; Wang K; Dong J; Chen Y ChemistryOpen; 2020 Feb; 9(2):176-182. PubMed ID: 32025462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]